Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection

Journal of Hospital Infection

Volumn 87, Issue 2, 2014, Pages 109-114

  Berry, N ^a   Sewell, B ^b   Jafri, S ^a   Puli, C ^a   Vagia, S ^a   Lewis, A M ^a   Davies, D ^c   Rees, E ^a   Ch'ng, C L ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Cell culture cytotoxin neutralization assay; Clinical diagnosis; Clostridium difficile; Glutamate dehydrogenase; Polymerase chain reaction; Toxin enzyme immuno assay

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; BACTERIUM DETECTION; CELL CULTURE CYTOTOXIN NEUTRALIZATION ASSAY; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOASSAY ANALYZER; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; CLOSTRIDIUM INFECTIONS; COMPARATIVE STUDY; DIARRHEA; EVALUATION STUDY; IMMUNOASSAY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84901652541     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.03.005     Document Type: Article

References (20)

1. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006, 145:758-764.
2. Monaghan T., Boswell T., Mahida Y.R. Recent advances in Clostridium difficile-associated disease. Gut 2008, 57:850-860.
3. Alcalá L., Martin A., Marín M., et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?. Clin Microbiol Infect 2012, 18:E204-E213.
4. Huttunen R., Vuento R., Syrjänen J., Tissari P., Aittoniemi J. Case fatality associated with a hypervirulent strain in patients with culture positive Clostridium difficile infection: a retrospective population based study. Int J Infect Dis 2012, 16:e532-e535.
5. Walk S.T., Micic D., Jain R., et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012, 55:1661-1668.
6. Alcalá L., Sánchez-Cambronero L., Catalán M.P., et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol 2008, 46:3833-3835.
7. Sloan L.M., Duresko B.J., Gustafson D.R., Rosenblatt J.E. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008, 46:1996-2001.
8. Eastwood K., Else P., Charlett A., Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217.
9. Goldenberg S.D., Clidd P.R., Smith S., Milner M., French G.L. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 2010, 74:48-54.
10. Tenover F.C., Baron E.J., Peterson L.R., Persing D.H. Laboratory diagnosis of Clostridium difficile infection. Can molecular amplification methods move us out of uncertainty?. J Mol Diagn 2011, 13:573-582.
11. Novak-Weekley S.M., Marlowe E.M., Miller J.M., et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010, 48:889-893.
12. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
13. Zidarič V., Kevorkijan B.K., Oresic N., Janezic S., Rupnik M. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory. J Med Microbiol 2011, 60:1131-1136.
14. Sewell B, Rees E, Thomas I, Ch'ng CL, Isaac M, Berry N. Impact on patient length of stay and cost effectiveness of rapid molecular testing for Clostridium difficile. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2012), 31st March-3rd April 2012, London, UK. Abstract P2274.
15. Barbut F, Eckert C, Visseaux B, et al. Impact of a rapid diagnosis on the management of patients suspected of Clostridium difficile infection. 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2012), 31st March-3rd April 2012, London, UK. Abstract P2279.
16. Dubberke E.R., Butler A.M., Reske K.A., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in non-surgical patients. Emerg Infect Dis 2008, 14:1031-1038.
17. Dubberke E.R., Han Z., Bobo L., et al. Impact of clinical symptoms on the interpretation of diagnostic assays for Clostridium difficile infection. J Clin Microbiol 2011, 49:2887-2893.
18. Goldenberg S.D. Laboratory diagnosis of Clostridium difficile. Lancet Infect Dis 2013, 13:909-910.
19. Khanna S., Pardi D.S., Rosenblatt J.E., Patel R., Kammer P.P., Baddour L.M. An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol 2012, 46:846-849.
20. Reilly J., Stewart S., Allardice G., et al. NHS Scotland National HAI prevalence survey. Final report 2007 2007, Health Protection Scotland, Edinburgh.